Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDImmunogen Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Immunogen Inc. Earnings Date And Information
Immunogen Inc. last posted its earnings results on Wednesday, March 6th, 2024. The company reported $-0.23 earnings per share for the quarter, missing analysts' consensus estimates of $0.13 by $0.36. The company had revenue of 113.43 M for the quarter and had revenue of 108.78 M for the year. Immunogen Inc. has generated $-1 earnings per share over the last year ($-0.87895012833605 diluted earnings per share) and currently has a price-to-earnings ratio of -35.54. Immunogen Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Immunogen Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/02/2023 | Q3 2023 | $0.04 | $0.10 | 0.06 | $20.47 M | $113.43 M |
| 07/31/2023 | Q2 2023 | -$0.16 | -$0.02 | 0.14 | $22.91 M | $83.15 M |
| 04/28/2023 | Q1 2023 | -$0.25 | -$0.16 | 0.09 | $17.79 M | $49.87 M |
| 03/01/2023 | Q4 2022 | -$0.29 | -$0.23 | 0.06 | $12.14 M | $41.17 M |
| 11/04/2022 | Q3 2022 | -$0.26 | -$0.31 | -0.05 | $52.22 M | $15.38 M |
| 08/01/2022 | Q2 2022 | N/A | -$0.25 | N/A | $20.83 M | $14.16 M |
| 05/06/2022 | Q1 2022 | -$0.21 | -$0.10 | 0.11 | $19.03 M | $38.08 M |
| 02/28/2022 | Q4 2021 | N/A | -$0.17 | N/A | $16.95 M | $27.99 M |
| 10/29/2021 | Q3 2021 | -$0.19 | -$0.18 | 0.01 | $17.73 M | $9.21 M |
| 07/30/2021 | Q2 2021 | -$0.18 | -$0.15 | 0.03 | $37.09 M | $16.95 M |
| 05/10/2021 | Q1 2021 | -$0.19 | -$0.17 | 0.02 | $25.18 M | $15.71 M |
| 03/01/2021 | Q4 2020 | N/A | $0.17 | N/A | $18.24 M | $85.80 M |
| 11/06/2020 | Q3 2020 | -$0.20 | -$0.13 | 0.07 | $11.72 M | $18.19 M |
| 08/05/2020 | Q2 2020 | N/A | -$0.14 | N/A | $74.77 M | $15.03 M |
| 05/05/2020 | Q1 2020 | N/A | -$0.17 | N/A | $15.94 M | $13.29 M |
| 03/11/2020 | Q4 2019 | N/A | $0.03 | N/A | $17.69 M | $44.86 M |
| 11/05/2019 | Q3 2019 | N/A | -$0.15 | N/A | $5.72 M | $13.28 M |
| 08/07/2019 | Q2 2019 | N/A | -$0.29 | N/A | $15.33 M | $15.54 M |
| 05/07/2019 | Q1 2019 | N/A | -$0.30 | N/A | $10.93 M | $8.58 M |
| 03/01/2019 | Q4 2018 | N/A | -$0.28 | N/A | $8.69 M | $13.79 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Immunogen Inc. Earnings: FAQ's
The conference call for Immunogen Inc.'s latest earnings report can be listened to online.
The conference call transcript for Immunogen Inc.'s latest earnings report can be read online.
Immunogen Inc. (:IMGN) has a recorded annual revenue of $108.78 M.
Immunogen Inc. (:IMGN) has a recorded net income of $-222,929,000.Immunogen Inc. has generated $-0.87895012833605 earnings per share over the last four quarters.
Immunogen Inc. (:IMGN) has a price-to-earnings ratio of -35.54 and price/earnings-to-growth ratio is -0.52.